Sacrospinous Hysteropexy Inferior to Manchester Procedure for Uterine Descent
WEDNESDAY, Aug. 23, 2023 (HealthDay News) -- For patients with uterine descent, sacrospinous hysteropexy is inferior to the Manchester procedure for first surgical treatment, according to a study published in the Aug. 15 issue of the Journal of the American Medical Association.
Rosa A. Enklaar, M.D., from Radboud University Medical Center in Nijmegen, the Netherlands, and colleagues compared the success of sacrospinous hysteropexy to the Manchester procedure for surgical treatment of uterine descent in a noninferiority randomized clinical trial involving 434 adults undergoing a first surgical treatment for uterine descent that did not protrude beyond the hymen.
The as-randomized analysis included 393 participants: 196 in the sacrospinous hysteropexy group and 197 in the Manchester procedure group. The researchers found that 77.0 and 87.3 percent of participants in the sacrospinous hysteropexy and Manchester procedure groups, respectively, achieved the composite outcome of success. However, the noninferiority criterion of −9 percent for the lower limit of the confidence interval was not met by sacrospinous hysteropexy (risk difference, −10.3 percent; 95 percent confidence interval, −17.8 to −2.8 percent; P = 0.63 for noninferiority). Perioperative outcomes and patient-reported outcomes did not differ between the groups at two-year follow-up.
"Patients who underwent the Manchester procedure had a better composite outcome of success after two-year follow-up, consistent with inferiority of sacrospinous hysteropexy," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
New Bill Would Ensure Free Exams for Sexual Assault Victims
THURSDAY, Oct. 27, 2022 (HealthDay News) -- After a sexual assault, some victims...
FDA Could OK Pfizer’s Booster Shots For All Adults This Week
WEDNESDAY, Nov. 17, 2021 (HealthDay News) -- The U.S. Food and Drug...
Statins Tied to Lower Risk of Parkinson’s-Like Symptoms
THURSDAY, March 24, 2022 (HealthDay News) -- Millions of people taking statin...